Vedolizumab treatment persistence and safety Presented ByDr S. Danese & Dr N.A. Cohen, Humanitas University, Milan, Italy TrialGEMINI ConferenceECCO 2020 14 April, 2020 14:04
Vedolizumab: Results from the GEMINI programme TrialPhase 3, GEMINI ConferenceECCO 2019 9 May, 2019 21:59
Vedolizumab in anti-TNF-naïve IBD patients and safety profile TrialGEMINI ConferenceECCO 2018 28 May, 2018 23:04
